Lung cancer combo therapy trial pulled before it began
NCT ID NCT00210171
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 30 times
Summary
This study planned to test a three-part treatment for advanced non-small cell lung cancer that cannot be removed by surgery. Patients would receive chemotherapy before, during, and after radiation therapy. However, the trial was withdrawn before enrolling any participants, so no data was collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33076, France
-
Centre de radiothérapie d'Agen
Agen, 47000, France
-
Clinique Francheville
Périgueux, 24000, France
-
Clinique Tivoli
Bordeaux, 33000, France
-
Hôpital Robert Boulin
Libourne, 33500, France
-
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, 33076, France
-
Polyclinique Bordeaux Nord
Bordeaux, 33000, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cisplatin and docetaxel (chemotherapy drugs)
What this could lead to
If successful, this approach could improve tumor response and survival for people with advanced lung cancer that cannot be surgically removed.
What could go wrong
The trial was withdrawn before any participants enrolled, so no results are available. Chemo-radiotherapy can cause significant side effects like fatigue, nausea, and low blood counts.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.